2
DAFTAR PUSTAKA Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR, 2011, MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (Diunduh tanggal 15 Oktober 2014). American Cancer Society, 2013, Breast Cancer Facts & Figures, Atlanta, Georgia (Diunduh tanggal 14 Oktober 2014). American Joint Comittee on Cancer, 2010, Breast Cancer Staging (Diunduh tanggal 14 Oktober 2014). Ander Urruticoechea, Ian E. Smith, Mitch Dowsett, 2005, Proliferation Marker Ki-67 in Early Breast Cancer (Diunduh tanggal 15 Oktober 2014). Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J,1992, Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections (Diunduh tanggal 15 Oktober 2014). E. C. Inwald, M. Klinkhammer-Schalke, F. Hofstädter, 2013, Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry Gerdes J, Scholzen T, 1980, The Ki-67 protein: from the known and the unknown (Diunduh tanggal 14 Oktober 2014). Haroon S, Hashmi A A, Khurshid A, Kanpurwala MA, Mujtuba S, Malik B, Faridi N, 2013, Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients (Diunduh tanggal 15 Oktober 2014). Inwald EC, Klinkhammer-Schalke M, Hofstädter F, et al,. 2013, Ki-67 is a prognostic parameter in breast cancer patients: 50

DAFTAR PUSTAKA

Embed Size (px)

DESCRIPTION

interna

Citation preview

Page 1: DAFTAR PUSTAKA

DAFTAR PUSTAKA

Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR, 2011, MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (Diunduh tanggal 15 Oktober 2014).

American Cancer Society, 2013, Breast Cancer Facts & Figures, Atlanta, Georgia (Diunduh tanggal 14 Oktober 2014).

American Joint Comittee on Cancer, 2010, Breast Cancer Staging (Diunduh tanggal 14 Oktober 2014).

Ander Urruticoechea, Ian E. Smith, Mitch Dowsett, 2005, Proliferation Marker Ki-67 in Early Breast Cancer (Diunduh tanggal 15 Oktober 2014).

Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J,1992, Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections (Diunduh tanggal 15 Oktober 2014).

E. C. Inwald, M. Klinkhammer-Schalke, F. Hofstädter, 2013, Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

Gerdes J, Scholzen T, 1980, The Ki-67 protein: from the known and the unknown (Diunduh tanggal 14 Oktober 2014).

Haroon S, Hashmi A A, Khurshid A, Kanpurwala MA, Mujtuba S, Malik B, Faridi N, 2013, Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients (Diunduh tanggal 15 Oktober 2014).

Inwald EC, Klinkhammer-Schalke M, Hofstädter F, et al,. 2013, Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry (Diunduh tanggal 15 Oktober 2014).

National Breast Cancer Foundation, 2014, http://www.nationalbreastcancer. org/causes-of-breast-cancer (Diunduh tanggal 14 Oktober 2014)

S Fasanella, E Leonard, C Cantaloni, et al,. 2011, Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies, (Diunduh tanggal 14 Oktober 2014).

50

Page 2: DAFTAR PUSTAKA

51

Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J, 1993, The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins (Diunduh tanggal 14 Oktober 2014).

Tan P.H, Jayabaskar T, Yip G, et al,. 2005, Phylloides Tumors Of TheBreast; the roles of pathologic parameters (Diunduh tanggal 15 Oktober 2014).

Wiesner FG, Magener A, Fasching PA, Wesse J, 2009, Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients (Diunduh tanggal 15 Oktober 2014).

World Health Organitation, 2002-2014, Breast malignant, Males, ChildrenBreast cancer (Diunduh tanggal 14 Oktober 2014).

Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA, 2010, Ki67 in breast cancer: prognostic and predictive potential (Diunduh tanggal 14 Oktober 2014).